525 studies found for:    "Alcon Research"
Show Display Options
Rank Status Study
1 Completed
Has Results
TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension
Condition: Ocular Inflammation Associated With Blepharaconjunctivitis
Interventions: Drug: Tobramycin 0.3%/Dexamethasone 0.05%;   Drug: TOBRADEX
2 Completed Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Intervention: Drug: olopatadine 0.2%
3 Completed
Has Results
Visual Function After Implantation of Bilateral AcrySoft ReSTOR Aspheric IOL
Condition: Cataract
Intervention: Device: AcrySof® ReSTOR® Aspheric IOL
4 Completed
Has Results
Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Olopatadine HCl Nasal Spray, 0.6%;   Drug: Azelastine HCl Nasal Spray, 0.1%
5 Completed
Has Results
Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age
Condition: Allergic Rhinitis
Interventions: Drug: Olopatadine Hydrochloride Nasal Spray 0.6%;   Drug: Olopatadine Hydrochloride Nasal Spray Vehicle
6 Completed
Has Results
Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis
Condition: Allergic Rhinitis
Intervention: Drug: Olopatadine 0.6% / Azelastine 137 mcg
7 Terminated
Has Results
Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)
Condition: Intraocular Pressure
Interventions: Drug: Travoprost 0.004% + Brinzolamide 1.0%;   Drug: Travoprost 0.004% + Tears Natural
8 Completed
Has Results
Surgeon Experience ReSTOR A +4 Intraocular Lens (IOL)
Condition: Cataract
Intervention: Device: ReSTOR
9 Completed
Has Results
DisCoVisc Comparative Evaluation
Condition: Cataracts
Interventions: Device: DisCoVisc;   Device: DuoVisc;   Device: BioVisc;   Device: Healon5;   Device: Amvisc Plus
10 Completed
Has Results
Low Cylinder Toric
Condition: Cataracts
Intervention: Device: Toric IOL (SN60T3)
11 Completed
Has Results
Contralateral ReSTOR / Monofocal or Phakic Eye
Condition: Cataracts
Intervention: Device: ReSTOR
12 Completed
Has Results
Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Olopatadine Hydrochloride Nasal Spray 0.6%;   Drug: Vehicle
13 Completed
Has Results
Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis
Condition: Vasomotor Rhinitis
Interventions: Drug: Olopatadine HCL (Patanase) Nasal Spray, 0.6%;   Drug: Azelastine HCl (Astelin) Nasal Spray, 137 mcg
14 Completed
Has Results
Assessment of Visual Performance in Patients With Low Levels of Astigmatism
Conditions: Cataract Extraction;   Corneal Astigmatism
Intervention: Other: Visual performance measures
15 Completed
Has Results
Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension
Condition: Glaucoma
Interventions: Drug: Travoprost 0.004% Ophthalmic Solution (Travatan);   Drug: Timolol 0.5% Ophthalmic Solution (Timoptic)
16 Recruiting Optimizing the Assessment of Refractive Outcomes After Cataract Surgery
Condition: Cataract
Interventions: Procedure: Manifest refraction;   Device: ACRYSOF® IQ Monofocal IOL Model SN60WF;   Device: Topcon® KR-1W Wave-Front Analyzer
17 Completed Clinical Investigation of Corneal Incision Size After Intraocular Lens (IOL) Implantation
Condition: Cataracts
Interventions: Device: UltraSert Preloaded Delivery System;   Device: iTec Preloaded Delivery System;   Device: iSert Preloaded Delivery System;   Device: Monarch III D Manual IOL Delivery System
18 Completed 24-hr Intraocular Pressure Control With SIMBRINZA ®
Condition: Glaucoma
Interventions: Drug: Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension;   Drug: Vehicle
19 Recruiting Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®
Conditions: Open-angle Glaucoma;   Ocular Hypertension
Interventions: Drug: Brinzolamide 1%/Brimonidine 0.2% suspension;   Drug: Brinzolamide/Brimonidine vehicle;   Drug: Travoprost 0.004%/Timolol 0.5% solution
20 Completed Clinical Evaluation of ACUVUE® OASYS® 1-Day and ACUVUE® OASYS®
Condition: Refractive Error
Interventions: Device: Senofilcon A contact lenses with HydraLuxe™;   Device: Senofilcon A contact lenses

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.